Clinical Trial Supply & Logistics for Pharmaceutical Market Intelligence Report - Global Forecast to 2027

Clinical Trial Supply & Logistics for Pharmaceutical Market Intelligence Report - Global Forecast to 2027

The Global Clinical Trial Supply & Logistics for Pharmaceutical Market is projected to reach USD 30,593.72 million by 2027 from USD 19,607.86 million in 2021, at a CAGR 7.69% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 7,698.04 million in 2021 and expected to reach USD 8,279.20 million in 2022, at a CAGR 7.65% to reach USD 11,983.99 million by 2027.
• The Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 4,383.33 million in 2021 and expected to reach USD 4,760.30 million in 2022, at a CAGR 7.99% to reach USD 6,955.17 million by 2027.
• The Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 7,526.48 million in 2021 and expected to reach USD 8,072.82 million in 2022, at a CAGR 7.55% to reach USD 11,654.56 million by 2027.

Market Segmentation & Coverage:

The report on clinical trial supply & logistics for pharmaceutical identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the clinical trial supply & logistics for pharmaceutical to forecast the revenues and analyze the trends in each of the following sub-markets:

Phase:

• BA/BE Studies
• Phase I
• Phase II
• Phase III
• Phase IV

Sector:

• Clinical Trial Logistics and Distributions
• Clinical Trial Manufacturing Services
• Clinical Trial Supply Chain Management

Therapeutic Area:

• Blood Disorders
• Digestive System Diseases
• Infectious and Immune System Diseases
• Neurological and Mental Disorders
• Oncology

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • Arizona
    • California
    • Florida
    • Illinois
    • New York
    • North Carolina
    • Ohio
    • Oregon
    • Pennsylvania
    • Tennessee
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Almac Group
• AmerisourceBergen Corporation
• Bilcare Limited
• Biocair International Limited
• Catalent, Inc.
• Clinigen Group PLC
• DHL International GmbH by Deutsche Post AG
• Eurofins Scientific SE
• FedEx Corporation
• ICON PLC
• Infosys Limited
• KLIFO A/S
• Lonza Group
• Marken
• Metrics Contract Services by Mayne Pharma group
• Movianto
• N-Side
• Parexel International Corporation
• PCI Pharma Services
• Seveillar Clinical Trial Supplies Pvt. Ltd.
• SIRO Clinpharm Private Limited
• Thermo Fisher Scientific, Inc.
• UDG Healthcare PLC

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 19,607.86 million

Estimated Year Value: USD 21,112.33 million

Forecast Year Value: USD 30,593.72 million

CAGR (%): 7.69%.

Please Note: PDF & Excel + Online Access - 1 Year